DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment



Oncology Homepage

Investigating focused ultrasound's veterinary applications Discovering newer, less invasive, ways to treat animal tumors

Philips to partner with Sun Nuclear Help physicians plan out feasible radiotherapy treatment options

New ultrasound imaging technique better detects prostate cancer SHI may yield a better value than MR for evaluating prostate

CIVCO Radiotherapy and Adaptiiv ink distribution deal Partnership will increase access to software that personalizes radiotherapy

California hospital first in country to perform a robotic bronchoscopy procedure Part of Monarch Platform clinical trial

Global CT scanner market to exceed $7 billion by 2024 Cone beam technology is driving the industry

Varian updates cancer imaging software with SIRT dosimetry capabilities Better comprehension of tumor response and normal-tissue toxicity

Proton therapy arrives in the UK First British patient has undergone a bout of proton therapy in South Wales

New camera inspired by butterfly eyes helps surgeons remove all cancerous tissue May cost as little as $200

RefleXion raises $100 million for world’s first biology-guided radiotherapy system Will be designed to irradiate multiple tumors in one session

Dr. Aaron Laviana

Lifting the veil on low-risk prostate cancer treatment costs

by Lauren Dubinsky , Senior Reporter
As the industry meanders from a fee-for-service model to accountable care organizations and bundled payments, understanding the true cost of services is a critical — and frequently baffling — challenge. By tracking the cost of different treatments for low-risk prostate cancer over 12 years, UCLA researchers have determined that the costs vary significantly from one treatment to the next.

The researchers arrived at this conclusion by using the time-driven activity based costing (TDABC) method of calculating total expenses. Unlike traditional costing methods, which are often arbitrary and lack transparency, the researchers believe the TDABC method yields greater insight into the true cost of care.

Story Continues Below Advertisement

The (#1 Resource) for Medical Imaging and Peripherals. Call 1-949-273-8000

As a Master Distributor for major brands Barco, Philips, and Sony, we offer custom imaging solutions. With our renowned OEM Solutions and Service/Repair Center, Ampronix is a one-stop shop for HD Medical LCD Displays--Printers--Recorders--4K Cameras

“By breaking down the costs of treatment to the individual process, we were able to see the exact cost of every step involved in treating localized, low-risk prostate cancer, allowing us to target areas of inefficiency and excess cost in the future,” Dr. Aaron Laviana, first author of the study, told HCB News. “This is also an important piece in the era of accountable care organizations, when health care providers and organizations are going to be held more accountable for all of their costs.”

The biggest surprise for Laviana was the relatively low cost of active surveillance, which involves repeat prostate-specific antigen (PSA) testing and prostate biopsies to track the occurrence of more aggressive disease in younger and healthier patients. But even though active surveillance costs about $7,298, 30 to 50 percent of patients choose definitive treatment instead.

The cost of intensity-modulated radiation therapy (IMRT) — $23,565 — is significantly more expensive than high-dose brachytherapy and stereotactic body radiation therapy, which cost $11,448 and $11,665 respectively. Low-dose rate brachytherapy is even less expensive at $8,978.

Robotic-assisted laparoscopic prostatectomy costs $16,946 because of the high price of the equipment and inpatient stays. Cryotherapy, which involves freezing the tumor, costs $11,215 because a single use of the equipment costs $6,292 compared to a single use of brachytherapy equipment, which is $1,869.

The next step for the researchers is to determine whether the differences in costs are connected to outcomes. Active surveillance is cheaper up front, but it has not been studied extensively, especially when considering that a significant number of patients choose another treatment.

“We are not advocating that treatment modalities be chosen solely on costs; rather, the collective picture needs to be analyzed when assessing the overall value (quality & costs) of each option,” said Laviana.

Oncology Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.